Rheumatoid Arthritis

Top news from across the health care landscape.

Intestinal microbiota may help predict rheumatoid arthritis symptom severity and frequency.

Approximately 1 in 100 patients with MGUS develop myeloma.

Vagus nerve stimulation may prove an effective RA treatment strategy.

Orencia ClickJect Autoinjector has an ergonomic design that may be beneficial for patients.

Orencia ClickJect Autoinjector has an ergonomic design that may be beneficial for patients.

Is the cost of specialty drugs worth the price in small patient populations?

Body mass index and smoking could have significant impact on RA remission.

Immunotherapy for lung cancer patients may cause other conditions to become worse.

Biodegradable polymer nanoparticles to deliver methotrexate may improve rheumatoid arthritis therapy.

Presence of different antibodies in the blood can influence response to abatacept regimen.

Anti-TNF-a monoclonal antibody treats moderate-to-severe plaque psoriasis and moderate-to-severe rheumatoid arthritis.

Some types of physical activity may increase the risk of rheumatoid arthritis.

Counseling sessions and text messages can help patients with rheumatoid arthritis become more active.

Rheumatoid arthritis drug shows improvements over methotrexate and Humira in quality of life and physical function.

Patients with rheumatoid arthritis taking glucocorticoids in certain doses may have an increased risk of developing diabetes.

Baricitinib shows statistically significant improvements in quality of life and physical function.

Researchers evaluate patient preferences in the treatment of rheumatoid arthritis.

Remicade treats rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis, and ulcerative colitis.

Specific venoms may lead to targeted therapies for conditions such as multiple sclerosis, rheumatoid arthritis, and other inflammatory disorders.

Survey indicates a disconnect among caregivers and the RA patients they treat.

Salt-inducible kinases found to limit the production of inflammatory molecules in human immune systems.

Baricitinib is a Janus-kinase inhibitor that interferes with intracellular enzymes in rheumatoid arthritis.

The cost of disease-modifying antirheumatic drugs for rheumatoid arthritis remains a concern.

Inflectra biosimilar treats conditions such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.